Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.11B |
| 2 |
NVIDIA
NVDA
|
+$2.59B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$2.58B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$2.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.21B |
| 2 |
Lam Research
LRCX
|
+$976M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$771M |
| 4 |
Warner Bros
WBD
|
+$771M |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$710M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.73% |
| 2 | Financials | 9.04% |
| 3 | Consumer Discretionary | 7.38% |
| 4 | Healthcare | 7.28% |
| 5 | Industrials | 6.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARTV
6151
Artiva Biotherapeutics
ARTV
$487M
| $73.8K | ﹤0.01% |
11,465
-595
| -5% | -$2.94K |
|
6152
ZKH Group
ZKH
$470M
| $73.7K | ﹤0.01% |
24,896
-3,913
| -14% | -$13.3K |
|
6153
Marchex
MCHX
$79.7M
| $73.5K | ﹤0.01% |
47,428
+2,515
| +6% | +$3.96K |
|
6154
Cato Corp
CATO
$65.9M
| $73.4K | ﹤0.01% |
25,941
-1,230
| -5% | -$3.79K |
|
|
AARD
6155
Aardvark Therapeutics
AARD
$138M
| $73.2K | ﹤0.01% |
19,404
-33,945
| -64% | -$352K |
|
|
QNC
6156
Quantum eMotion
QNC
$458M
| $73K | ﹤0.01% |
+31,896
| New | +$93K |
|
6157
CION Investment
CION
$297M
| $71.9K | ﹤0.01% |
+10,508
| New | +$88.3K |
|
6158
Laird Superfood
LSF
$46.2M
| $71.7K | ﹤0.01% |
33,366
+1,423
| +4% | +$3.82K |
|
|
BNAIW
6159
Brand Engagement Network Warrant
BNAIW
$2.26M
| $71.2K | ﹤0.01% |
273,919
| – | – |
|
6160
Spruce Power Holding Corp
SPRU
$39.9M
| $71.1K | ﹤0.01% |
17,337
-735
| -4% | -$3.4K |
|
6161
Actinium Pharmaceuticals
ATNM
$27M
| $69.9K | ﹤0.01% |
70,241
-117
| -0.2% | -$139 |
|
|
FLNA
6162
Filana Therapeutics
FLNA
$43M
| $69.8K | ﹤0.01% |
41,324
+8,335
| +25% | +$17.2K |
|
|
WPRT
6163
Westport Fuel Systems
WPRT
$36.5M
| $69.6K | ﹤0.01% |
38,245
-508
| -1% | -$1.02K |
|
6164
Alpha Tau Medical Warrant
DRTSW
$74.4M
| $69.4K | ﹤0.01% |
69,409
| – | – |
|
6165
Siebert Financial
SIEB
$68M
| $69.3K | ﹤0.01% |
36,068
-4,065
| -10% | -$10.2K |
|
6166
Spectral AI Warrants
MDAIW
$5.79M
| $69.2K | ﹤0.01% |
123,629
| – | – |
|
6167
Pyxis Oncology
PYXS
$165M
| $68.5K | ﹤0.01% |
46,920
-39,225
| -46% | -$59.1K |
|
6168
Metalpha Technology Holding
MATH
$39.1M
| $68.1K | ﹤0.01% |
59,220
-20,124
| -25% | -$31.6K |
|
|
BZUN
6169
Baozun
BZUN
$144M
| $67.7K | ﹤0.01% |
28,322
-62,136
| -69% | -$162K |
|
|
SLMT
6170
Brera Holdings
SLMT
$42.6M
| $67.7K | ﹤0.01% |
+8,632
| New | +$114K |
|
|
NXXT
6171
NextNRG Inc
NXXT
$50.7M
| $66.2K | ﹤0.01% |
165,475
+68,211
| +70% | +$53.7K |
|
6172
Cardlytics
CDLX
$21M
| $64.8K | ﹤0.01% |
6,172
-4,728
| -43% | -$46.1K |
|
|
TGEN
6173
Tecogen Inc
TGEN
$96.3M
| $64.3K | ﹤0.01% |
25,106
-42,618
| -63% | -$157K |
|
|
FRMI
6174
PUT
Fermi Inc
FRMI
$4.72B
| $64.2K | ﹤0.01% |
+11,000
| New | +$96.3K |
|
6175
Lifezone Metals Ltd Warrants
LZM.WS
| $64.1K | ﹤0.01% |
156,400
| – | – |
|
Similar funds
Goldman Sachs's Q1 2026 Portfolio in Review
As of Q1 2026, Goldman Sachs held 7,166 positions worth $871B, up 6.8% from $815B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs deployed $86.3B of net new capital in Q1 2026, opening 752 new positions and adding to 3,118 existing holdings. Its largest new stake was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, an estimated $1.21B trimmed.
- Goldman Sachs's largest Q1 2026 buy was ProShares GENIUS Money Market ETF: 2,704,103 shares worth $271M.
- Goldman Sachs added most to Microsoft in Q1 2026, an estimated $4.11B increase.
- Goldman Sachs's biggest Q1 2026 reduction was State Street SPDR Dow Jones Industrial Average ETF Trust, cutting an estimated $1.21B.
- Goldman Sachs fully exited Dayforce in Q1 2026, selling an estimated $441M.
- Goldman Sachs's ten largest holdings make up 20% of its $871B portfolio in Q1 2026.
- Goldman Sachs opened 752 new positions and closed 735 in Q1 2026.
- Goldman Sachs's portfolio value rose 6.8% quarter-over-quarter to $871B.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.